|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/155 | (2006.01) |
| C07K 14/135 | (2006.01) |
| (11) | Number of the document | 2988780 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14719022.7 |
| Date of filing the European patent application | 2014-04-24 | |
| (97) | Date of publication of the European application | 2016-03-02 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-26 |
| (46) | Date of publication of the claims translation | 2019-03-12 |
| (86) | Number | PCT/EP2014/058353 |
| Date | 2014-04-24 |
| (87) | Number | WO 2014/174018 |
| Date | 2014-10-30 |
| (30) | Number | Date | Country code |
| 13165402 | 2013-04-25 | EP |
| (72) |
LANGEDIJK, Johannes Petrus Maria, NL
KRARUP, Anders, NL
|
| (73) |
Janssen Vaccines & Prevention B.V.,
Archimedesweg 4, 2333 CN Leiden,
NL
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Stabilizuoti tirpūs RSV F polipeptidai prieš suliejimą |
| STABILIZED SOLUBLE PREFUSION RSV F POLYPEPTIDES |
| Payment date | Validity (years) | Amount | |
| 2024-04-08 | 11 | 289.00 EUR |
| 2025-04-24 |